NL
DE
24 January 2020
In addition, novel methods for targeted delivery will be developed. The results will be crucial for the clinical implementation of oligonucleotide-based therapies.
In addition, novel methods for targeted delivery will be developed. The results will be crucial for the clinical implementation of oligonucleotide-based therapies.
Related news items
'Stofwisselkracht' grant for Paola de Haas and Alessandra Cambi
5 December 2019 Paola de Haas and Alessandra Cambi, theme Nanomedicine, have recently been awarded a grant from ‘Stichting Stofwisselkracht’ for their project entitled “Identification of immune-related symptoms in Congenital Disorders of Glycosylation”. read more
Podosome nanoscale architecture redefined
20 November 2019 Koen van den Dries and Alessandra Cambi, theme Nanomedicine, revealed how the nanoscale architecture of podosomes enables dendritic cells to protrude and sense their extracellular environment. They have published their results in Nature Communications. read more
MMD Lecturer of the year award for Alessandra Cambi
16 September 2019 At their annual MMD symposium, Alessandra Cambi, theme Nanomedicine, was chosen as lecturer of the year 2018-2019 of the Top Master "Molecular mechanisms of disease". read more
RIMLS PhD grants awarded to eight RIMLS (j)PI's
12 September 2019 Recently, RIMLS held an internal call for Radboudumc junior researcher (PhD) positions. Congratulations for all the awardees and all the best in conducting the research projects. read more
